Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9110
pubmed:dateCreated
1998-7-1
pubmed:abstractText
Retrospective studies show significant improvements in survival among women who had breast cancer resected during the luteal phase of their menstrual cycle compared with the follicular phase. We hypothesised that tumour tissue would show cyclical changes in expression of genes whose products might contribute to metastatic potential.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0140-6736
pubmed:author
pubmed:issnType
Print
pubmed:day
18
pubmed:volume
351
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1170-3
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9643688-Adult, pubmed-meshheading:9643688-Blotting, Northern, pubmed-meshheading:9643688-Breast Neoplasms, pubmed-meshheading:9643688-Carcinoma, Ductal, Breast, pubmed-meshheading:9643688-Cell Division, pubmed-meshheading:9643688-Female, pubmed-meshheading:9643688-Gene Expression Regulation, Enzymologic, pubmed-meshheading:9643688-Gene Expression Regulation, Neoplastic, pubmed-meshheading:9643688-Gonadal Steroid Hormones, pubmed-meshheading:9643688-Humans, pubmed-meshheading:9643688-Mastectomy, Segmental, pubmed-meshheading:9643688-Menstrual Cycle, pubmed-meshheading:9643688-Middle Aged, pubmed-meshheading:9643688-Neoplasm Metastasis, pubmed-meshheading:9643688-Peptide Hydrolases, pubmed-meshheading:9643688-Prognosis, pubmed-meshheading:9643688-RNA, Messenger, pubmed-meshheading:9643688-Survival Rate
pubmed:year
1998
pubmed:articleTitle
Expression of genes that contribute to proliferative and metastatic ability in breast cancer resected during various menstrual phases.
pubmed:affiliation
London Regional Cancer Center, Ontario, Canada.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't